Models for the in vitro assessment of neurotoxicity in the nervous system in relation to xenobiotic and neurotrophic factor-mediated events.
We have been investigating the use of three culture types for both screening and mechanistic neurotoxicology in vitro. These are the neuroblastoma cell lines (IMR32 - human; C-1300 - mouse), primary mixed monolayer cultures of the rat and chick embryonic midbrain ('micromass' systems) and organotypic whole rat brain reaggregate cultures. The performance of these models for neurotoxicity resting has been investigated with ethylcholine mustard aziridinium (ECMA), vincristine, aluminium, glutamate receptor antagonists, MPTP, and 'hypothyroidism'. From a 'screening' viewpoint, in vitro exposure through a tiered testing system (ranging from simple cytotoxicological parameters in the neural cell lines to neurotransmitter measurements in the organotypic cultures) may permit detection of CNS neurotoxicity and delineation of possible mechanisms. The type of developmental neurotoxicological information gained is highlighted in the cases of aluminum and the glutamate receptor antagonists. High concentrations of aluminum caused significant neural cell death in differentiated neuroblastoma cell lines after approximately two weeks exposure in vitro. In contrast, cell death was detected in the developing midbrain cultures as early as 24 - 48 hr. Studies in whole brain reaggregates suggest that cholinotoxicity may occur in a similar time-frame and is consistent with some of aluminium's effects in vivo. Preliminary experiments have shown that exposure of immature developing midbrain rat primary cultured neurones to the glutamate receptor antagonists, AP3 and MK-801 induces neural cell death which may relate to control of NGF by glutamate cells. Developing neural culture systems may prove useful for testing agents which cause neurotoxicity through disturbances of neurotrophic function.
Atterwill
C K
CK
CellTox Centre, Hatfield Polytechnic, Herts, United Kingdom.
Johnston
H
H
Thomas
S M
SM
D000535:Aluminum / Q000633:toxicity; D000077410:Aluminum Chloride; D017607:Aluminum Compounds; D000818:Animals; D001388:Aziridines / Q000633:toxicity; D001921:Brain / Q000187:drug effects; D002478:Cells, Cultured; D002712:Chlorides / Q000633:toxicity; D002794:Choline / Q000031:analogs & derivatives / Q000633:toxicity; D006728:Hormones / Q000502:physiology; D006801:Humans; D008636:Mesencephalon / Q000187:drug effects; D008954:Models, Biological; D009414:Nerve Growth Factors / Q000502:physiology*; D009420:Nervous System / Q000187:drug effects*; D009474:Neurons / Q000187:drug effects; D014750:Vincristine / Q000633:toxicity; D015262:Xenobiotics / Q000633:toxicity*
D017607:Aluminum Compounds; D001388:Aziridines; D002712:Chlorides; D006728:Hormones; D009414:Nerve Growth Factors; D015262:Xenobiotics; D000077410:Aluminum Chloride; D014750:Vincristine; C044894:ethylcholine aziridinium; D000535:Aluminum; D002794:Choline